GE HealthCare recasts results under new Advanced Imaging Solutions segment
Filed with the SEC on · Summarized by InvestorsBot
GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new Advanced Imaging Solutions segment in the second quarter of 2026, leaving three reportable segments: AIS, Pharmaceutical Diagnostics, and Patient Care Solutions. Recast first-quarter 2026 revenue was $5.131 billion, including $3.640 billion from AIS, $770 million from PDx, and $704 million from PCS; organic revenue grew 4.0% for AIS and 9.7% for PDx but declined 8.1% for PCS. The unaudited historical information, provided July 29, 2026, is intended to improve comparability and does not change previously reported financial statements.